A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

PHASE2RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 19, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Interventions
DRUG

IMVT-1402

Dose 1 or Dose 2 SC QW

DRUG

Placebo

Matching Placebo SC QW

Trial Locations (70)

918

RECRUITING

Site Number - 1036, San Juan

1257

RECRUITING

Site Number - 5601, Sofia

1406

RECRUITING

Site Number -5004, CABA

1431

RECRUITING

Site Number - 5603, Sofia

1606

RECRUITING

Site Number - 5600, Sofia

1618

RECRUITING

Site Number - 5605, Sofia

1680

RECRUITING

Site Number - 5606, Sofia

8916

RECRUITING

Site Number - 7104, Badalona

11000

RECRUITING

Site Number - 9000, Belgrade

12462

RECRUITING

Site Number - 3900, Attiki

16121

RECRUITING

Site Number - 3901, Athens

17033

RECRUITING

Site Number - 1002, Hershey

21000

RECRUITING

Site Number - 9003, Novi Sad

26133

RECRUITING

Site Number - 6501, Oldenburg

28003

RECRUITING

Site Number - 7100, Madrid

28041

RECRUITING

Site Number - 7102, Madrid

29016

RECRUITING

Site Number - 7103, Málaga

31008

RECRUITING

Site Number - 7105, Pamplona

32819

RECRUITING

Site Number - 1025, Orlando

33012

RECRUITING

Site Number - 1014, Hialeah

33122

RECRUITING

Site Number - 1028, Miami

33133

RECRUITING

Site Number - 1024, Miami

44791

RECRUITING

Site Number - 6503, Bochum

46100

RECRUITING

Site Number - 7101, Burjassot

56403

RECRUITING

Site Number - 3903, Thessaloniki

RECRUITING

Site Number - 3905, Thessaloniki

71110

RECRUITING

Site Number - 3906, Heraklion

72076

RECRUITING

Site Number - 6502, Tübingen

75061

RECRUITING

Site Number - 1012, Irving

85037

RECRUITING

Site Number - 1038, Phoenix

85260

RECRUITING

Site Number - 1034, Scottsdale

90045

RECRUITING

Site Number - 1023, Los Angeles

90211

RECRUITING

Site Number - 1022, Beverly Hills

91054

RECRUITING

Site Number - 6500, Erlangen

91910

RECRUITING

Site Number - 1018, Chula Vista

94538

RECRUITING

Site Number - 1005, Fremont

36207-4780

RECRUITING

Site Number - 1010, Anniston

35203-4050

RECRUITING

Site Number - 1020, Birmingham

80045-2541

RECRUITING

Site Number - 1000, Aurora

80109-8034

RECRUITING

Site Number - 1033, Castle Rock

06030-2840

RECRUITING

Site Number - 1021, Farmington

33014-5602

RECRUITING

Site Number - 1011, Miami Lakes

30518-8721

RECRUITING

Site Number - 1009, Buford

02135

RECRUITING

Site Number - 1030, Brighton

48326-3396

RECRUITING

Site Number - 1019, Auburn Hills

48081-1274

RECRUITING

Site Number - 1003, Saint Clair Shores

48084 3536

RECRUITING

Site Number - 1013, Troy

64506-2459

RECRUITING

Site Number - 1004, Saint Joseph

28211-1064

RECRUITING

Site Number - 1007, Charlotte

27577-4664

RECRUITING

Site Number - 1006, Smithfield

19103-4708

RECRUITING

Site Number - 1015, Philadelphia

C1023AAB

RECRUITING

Site Number - 5000, CABA

C1425DND

RECRUITING

Site Number - 5001, CABA

T4000IHE

RECRUITING

Site Number - 5003, San Miguel de Tucumán

0112

RECRUITING

Site Number - 8002, Tbilisi

0160

RECRUITING

Site Number - 8000, Tbilisi

104 31

RECRUITING

Site Number - 3902, Attiki

411 10

RECRUITING

Site Number - 3904, Larissa

60-702

RECRUITING

Site Number - 3004, Poznan

66-400

RECRUITING

Site Number - 3005, Gorzów Wielkopolski

00-716

RECRUITING

Site Number - 3000, Warsaw

00-874

RECRUITING

Site Number - 3001, Warsaw

35-055

RECRUITING

Site Number - 3006, Rzeszów

35-309

RECRUITING

Site Number - 3002, Rzeszów

90-436

RECRUITING

Site Number - 3003, Lodz

00725-2443

RECRUITING

Site Number-1029, Caguas

00716-0377

RECRUITING

Site Number - 1037, Ponce

L22 0LG

RECRUITING

Site Number - 7000, Liverpool

LS7 4SA

RECRUITING

Site Number - 7002, Leeds

SE1 9RT

RECRUITING

Site Number - 7003, London

Sponsors
All Listed Sponsors
lead

Immunovant Sciences GmbH

INDUSTRY

NCT06980805 - A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) | Biotech Hunter | Biotech Hunter